Introduction
PD is the second most common neurodegenerative disorder after Alzheimer's disease, affecting approximately 1 per cent of the geriatric population.
1 It is characterized clinically by resting tremor, bradykinesia, rigidity and postural imbalance. The etiology of PD still remains unknown. Various factors implicated in the pathogenesis of PD, include the oxidant stress hypothesis which has been implicated to play a major role in neuronal cell death associated with PD. 3 The studies of the CNS are beset with the complexity of direct investigation because of the inaccessibility of the neural tissue, and hence the difficulty in obtaining a brain biopsy, until after the death of the affected individual. It is, therefore, imperative to search suitable biomarkers, which can help in the diagnosis of PD during life. Aquaporin (AQP4) is a water channel protein in mammalian brain, which is expressed in plasma membrane of astrocyte assisting in astrocytic migration and proliferation. AQP4 plays an important role in water homeostasis in the brain and brain edema. 4 Recently, AQP4 expression has been reported to be involved in the pathophysiology of the development of PD using MPTP in mice. 5 Further, various markers of lipid peroxidation and oxidative damage to DNA are increased in the substantia nigra of Parkinsonian patients.
6-8 These phenomena may be the consequence of reduced efficiency of endogenous antioxidants, such as glutathione that may render PD patients more vulnerable to oxidative stress. Indeed, concentrations of reduced or total glutathione are decreased in the substantia nigra of this patients 9-11 while the activity of SOD is increased. Slight increase in the concentrations of cytosolic and mitochondrial isoforms of SOD (Cu/Zn SOD and Mn SOD, respectively) have been reported in lymphocytes of PD patients. These increases, however, were mostly related to the intake of the MAO-B inhibitor selegiline.
12,13 On the other hand, certain other authors have reported decreased total SOD activity and increased concentrations of malondialdehyde (a product of lipid peroxidation) in erythrocytes, serum, and plasma of PD patients.
14-16 To ascertain 
RNA extraction and RT-PCR for AQP4
Total RNA was extracted using RNA isolation kit and used for RT-PCR analysis. The primer used for AQP4 was as follows: Forward 5'-'GGAATCCTCTATCTGGTCACA -3' reverse 5'-TGTTTGCT-GGGCAGCTTTGCT-3' and β-actin forward 5'-GTGGGGCGCCCCA-GGCACCA-3' reverse 5'-CTTCCTTAATGTCACGCACGATTTC-3'. The thermal cycling conditions of the PCR were for 94 
Statistics
The data were evaluated with SPSS/10 software. Hypothesis testing methods included one way analysis of variance followed by least significant difference test. p values of less than 0.05 were considered to indicate statistical significance. All these results were expressed as mean ± SEM.
Results
The PCR results showed following trend: Beta actin served as internal control. 
Discussion
Reduced glutathione is an important intracellular free radical scavenger which is synthesized in the brain by both neurons and glial cells, although it is more abundant within astrocytes. Its role is to detoxify hydrogen peroxide (H 2 O 2 ) to water and molecular oxygen. 23 This important role for glutathione has been proposed in the pathogenesis of PD because a decrease in total glutathione concentration in the substantia nigra has been observed in preclinical stages in PD patients. Such depletion of glutathione triggers cascades of events, which may ultimately result in cell death.
24 which could be attributed to concurrent elevation in glutathione. An increased level of LPO was also observed in PD patient's blood sample when compared with healthy controls. It is said that the loss of dopaminergic neurons in PD would lead to enhanced metabolism of dopamine, augmenting the formation of H 2 O 2 resulting in the generation of highly neurotoxic hydroxyl radicals. 25 This argument, however, is well suited for the brain tissue and could not justify the current observation of LPO levels in a blood of the patients. It is interesting to note similar GSH-LPO status of substantua nigra region was found in preclinical stages of PD. 26 Further, decreased activities of SOD, CAT and GPx were found in the patient's blood which could be interpreted as a compensatory response to enhanced formation of superoxide radicles and also increase the production of highly deleterious H 2 O 2 in the blood.
27, 28 The study shows the redox status in blood of PD patients which is quite similar to that brain of PD patients occurring due to astrocytic/dopaminergic variations in them. AQP4 which is redox regulated channel, also showed a marked variation in the current study in the blood of PD patients. The role of AQP4 in PD is not fully understood. In this study the down regulation of AQP4 mRNA was seen in PD patients when compared with age matched healthy control and this change in the expression of AQP4 is not influenced by the stages between Hoehn and Yahr. This deficiency of AQP4 has been speculated to be the factor involved in mediating enhanced sensitivity of dopaminergic neurons to neurotoxicity/oxidant burden, by the modulation of astrocytes which provide precursors for redox-modulating components and also neurotrophic factors.
29
Our earlier observation showed an elevated LPO with attenuated anti oxidants in MPTP treated mice brain 30 along with down regulated AQP4 mRNA (unpublished data). This data and the current observation support the recent theory of involvement of AQP4 in PD pathology.
